Klingman & Associates, LLC Abbott Laboratories Transaction History

Klingman & Associates, LLC

  • $1.61 Billion
  • Q3 2024

A detailed history of Klingman & Associates, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Klingman & Associates, LLC holds 11,391 shares of ABT stock, worth $1.4 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
11,391
Previous 7,702 47.9%
Holding current value
$1.4 Million
Previous $800,000 62.25%
% of portfolio
0.08%
Previous 0.05%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024
BUY
$100.07 - $118.13 $369,158 - $435,781
3,689 Added 47.9%
11,391 $1.3 Million
Q2 2024

Jul 30, 2024
BUY
$100.73 - $112.44 $51,170 - $57,119
508 Added 7.06%
7,702 $800,000
Q1 2024

May 01, 2024
SELL
$109.52 - $120.96 $4,052 - $4,475
-37 Reduced 0.51%
7,194 $817,000
Q4 2023

Jan 29, 2024
SELL
$90.19 - $110.4 $42,840 - $52,440
-475 Reduced 6.16%
7,231 $795,000
Q3 2023

Oct 30, 2023
SELL
$95.53 - $114.62 $22,067 - $26,477
-231 Reduced 2.91%
7,706 $746,000
Q2 2023

Jul 31, 2023
SELL
$100.78 - $112.29 $24,086 - $26,837
-239 Reduced 2.92%
7,937 $865,000
Q1 2023

May 03, 2023
SELL
$96.86 - $114.01 $12,301 - $14,479
-127 Reduced 1.53%
8,176 $827,000
Q4 2022

Feb 03, 2023
SELL
$95.06 - $111.52 $121,106 - $142,076
-1,274 Reduced 13.3%
8,303 $911,000
Q3 2022

Oct 28, 2022
BUY
$96.76 - $112.03 $13,159 - $15,236
136 Added 1.44%
9,577 $927,000
Q2 2022

Jul 27, 2022
BUY
$102.07 - $123.37 $4,695 - $5,675
46 Added 0.49%
9,441 $1.03 Million
Q1 2022

May 06, 2022
BUY
$114.02 - $139.04 $409,901 - $499,848
3,595 Added 61.98%
9,395 $1.11 Million
Q4 2021

Jan 31, 2022
BUY
$115.53 - $141.46 $6,007 - $7,355
52 Added 0.9%
5,800 $816,000
Q3 2021

Nov 01, 2021
BUY
$116.66 - $129.06 $183,272 - $202,753
1,571 Added 37.61%
5,748 $679,000
Q2 2021

Jul 27, 2021
SELL
$105.79 - $124.53 $68,551 - $80,695
-648 Reduced 13.43%
4,177 $484,000
Q1 2021

Apr 29, 2021
BUY
$108.84 - $128.23 $74,337 - $87,581
683 Added 16.49%
4,825 $578,000
Q4 2020

Feb 09, 2021
BUY
$105.0 - $114.42 $22,680 - $24,714
216 Added 5.5%
4,142 $454,000
Q3 2020

Nov 03, 2020
BUY
$91.64 - $111.29 $150,564 - $182,849
1,643 Added 71.97%
3,926 $427,000
Q2 2020

Aug 04, 2020
BUY
$76.57 - $98.0 $174,809 - $223,734
2,283 New
2,283 $209,000
Q1 2020

Apr 29, 2020
SELL
$62.82 - $91.86 $159,311 - $232,956
-2,536 Closed
0 $0
Q4 2019

Jan 29, 2020
BUY
$78.51 - $87.4 $199,101 - $221,646
2,536 New
2,536 $220,000

Others Institutions Holding ABT

# of Institutions
3,204
Shares Held
1.3B
Call Options Held
8.74M
Put Options Held
8.08M
View Full List

About ABBOTT LABORATORIES

ABT Quotes by TradingView
  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $216B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Klingman & Associates, LLC Portfolio

Follow Klingman & Associates, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Klingman & Associates, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Klingman & Associates, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email